GENE ONLINE|News &
Opinion
Blog

Breast Cancer
Alymsys Becomes the Third Biosimilar for Bevacizumab Approved by FDA
2022-04-20
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Eli Lilly’s Early Breast Cancer Drug Gets FDA Nod but Faces Tricky Rollout
2021-10-14
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
Day 2 ASCO 2021 Roundup: Focus on Equity in Cancer Care, Highlights from Breast Cancer and Gastrointestinal Cancer Studies
2021-06-06
R&D
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
R&D
New Strategies to Improve Adoptive Cell Therapies for Solid Tumors
2021-04-14
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
FDA Rejects Athenex’s Breast Cancer Treatment, Recommends Another Clinical Trial
2021-03-03
Roche Bags EU Nod for a Novel Delivery Method in Breast Cancer Treatment
2020-12-25
Roche’s Cobas PIK3CA Mutation Test – A Blessing for Breast Cancer Patients
2020-12-20
Spotlight: Novartis’ Kisqali Shows Promising Results in Metastatic Breast Cancer
2020-12-18
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
Lilly’s Trailblazer Makes Headway in Breast Cancer Therapy
2020-09-23
1 2 3 4
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!